JP2017509639A - 体重管理にシンナムアルデヒド及び亜鉛を用いるための方法及び組成物 - Google Patents
体重管理にシンナムアルデヒド及び亜鉛を用いるための方法及び組成物 Download PDFInfo
- Publication number
- JP2017509639A JP2017509639A JP2016557635A JP2016557635A JP2017509639A JP 2017509639 A JP2017509639 A JP 2017509639A JP 2016557635 A JP2016557635 A JP 2016557635A JP 2016557635 A JP2016557635 A JP 2016557635A JP 2017509639 A JP2017509639 A JP 2017509639A
- Authority
- JP
- Japan
- Prior art keywords
- cinnamaldehyde
- composition
- zinc
- weight loss
- ppm
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-cinnamaldehyde Chemical compound O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 title claims abstract description 89
- 229940117916 cinnamic aldehyde Drugs 0.000 title claims abstract description 89
- KJPRLNWUNMBNBZ-UHFFFAOYSA-N cinnamic aldehyde Natural products O=CC=CC1=CC=CC=C1 KJPRLNWUNMBNBZ-UHFFFAOYSA-N 0.000 title claims abstract description 89
- 239000000203 mixture Substances 0.000 title claims abstract description 61
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 title claims abstract description 50
- 239000011701 zinc Substances 0.000 title claims abstract description 50
- 229910052725 zinc Inorganic materials 0.000 title claims abstract description 50
- 238000000034 method Methods 0.000 title claims abstract description 29
- 230000037221 weight management Effects 0.000 title abstract description 7
- 230000000694 effects Effects 0.000 claims abstract description 30
- 235000013305 food Nutrition 0.000 claims abstract description 29
- 230000004580 weight loss Effects 0.000 claims abstract description 27
- 230000003647 oxidation Effects 0.000 claims abstract description 25
- 238000007254 oxidation reaction Methods 0.000 claims abstract description 25
- 210000002820 sympathetic nervous system Anatomy 0.000 claims abstract description 16
- 208000008589 Obesity Diseases 0.000 claims abstract description 15
- 235000020824 obesity Nutrition 0.000 claims abstract description 15
- 206010033307 Overweight Diseases 0.000 claims abstract description 12
- 230000001737 promoting effect Effects 0.000 claims abstract description 7
- 239000003925 fat Substances 0.000 claims description 30
- 235000005911 diet Nutrition 0.000 claims description 10
- 230000037213 diet Effects 0.000 claims description 9
- 238000012423 maintenance Methods 0.000 claims description 7
- 238000012549 training Methods 0.000 claims description 7
- 235000017803 cinnamon Nutrition 0.000 claims description 6
- 235000014633 carbohydrates Nutrition 0.000 claims description 4
- 150000001720 carbohydrates Chemical class 0.000 claims description 4
- 235000020845 low-calorie diet Nutrition 0.000 claims description 4
- 102000004169 proteins and genes Human genes 0.000 claims description 4
- 108090000623 proteins and genes Proteins 0.000 claims description 4
- 239000000341 volatile oil Substances 0.000 claims description 4
- 235000015263 low fat diet Nutrition 0.000 claims description 3
- 235000020855 low-carbohydrate diet Nutrition 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 241000723347 Cinnamomum Species 0.000 claims 1
- 235000015872 dietary supplement Nutrition 0.000 abstract description 7
- 241000282414 Homo sapiens Species 0.000 abstract description 6
- 230000035807 sensation Effects 0.000 abstract description 4
- 239000003814 drug Substances 0.000 abstract description 3
- 229940079593 drug Drugs 0.000 abstract description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract description 2
- 230000008093 supporting effect Effects 0.000 abstract description 2
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 40
- 150000001875 compounds Chemical class 0.000 description 22
- 235000017663 capsaicin Nutrition 0.000 description 20
- 229960002504 capsaicin Drugs 0.000 description 20
- 230000037406 food intake Effects 0.000 description 16
- 230000008901 benefit Effects 0.000 description 14
- 208000016261 weight loss Diseases 0.000 description 13
- 238000011282 treatment Methods 0.000 description 12
- 238000005265 energy consumption Methods 0.000 description 11
- 101000764872 Homo sapiens Transient receptor potential cation channel subfamily A member 1 Proteins 0.000 description 9
- 102100026186 Transient receptor potential cation channel subfamily A member 1 Human genes 0.000 description 9
- 201000010099 disease Diseases 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 230000001965 increasing effect Effects 0.000 description 9
- 241000124008 Mammalia Species 0.000 description 7
- 241001465754 Metazoa Species 0.000 description 7
- 239000000796 flavoring agent Substances 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 230000006870 function Effects 0.000 description 6
- 235000016709 nutrition Nutrition 0.000 description 6
- 230000000291 postprandial effect Effects 0.000 description 6
- 230000002195 synergetic effect Effects 0.000 description 6
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 5
- 241000282412 Homo Species 0.000 description 5
- 235000013409 condiments Nutrition 0.000 description 5
- 235000003130 Arctium lappa Nutrition 0.000 description 4
- 244000294263 Arctium minus Species 0.000 description 4
- 235000008078 Arctium minus Nutrition 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 239000003995 emulsifying agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 235000013336 milk Nutrition 0.000 description 4
- 239000008267 milk Substances 0.000 description 4
- 210000004080 milk Anatomy 0.000 description 4
- -1 penetrant Substances 0.000 description 4
- 229940068196 placebo Drugs 0.000 description 4
- 239000000902 placebo Substances 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- 244000203593 Piper nigrum Species 0.000 description 3
- 235000008184 Piper nigrum Nutrition 0.000 description 3
- 229940112822 chewing gum Drugs 0.000 description 3
- 235000015218 chewing gum Nutrition 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 235000013365 dairy product Nutrition 0.000 description 3
- 235000013355 food flavoring agent Nutrition 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 235000019615 sensations Nutrition 0.000 description 3
- 235000013599 spices Nutrition 0.000 description 3
- 230000000638 stimulation Effects 0.000 description 3
- 230000001502 supplementing effect Effects 0.000 description 3
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 2
- 240000003291 Armoracia rusticana Species 0.000 description 2
- 235000011330 Armoracia rusticana Nutrition 0.000 description 2
- 244000056139 Brassica cretica Species 0.000 description 2
- 235000003351 Brassica cretica Nutrition 0.000 description 2
- 235000003343 Brassica rupestris Nutrition 0.000 description 2
- 206010006784 Burning sensation Diseases 0.000 description 2
- 206010061818 Disease progression Diseases 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 108010037150 Transient Receptor Potential Channels Proteins 0.000 description 2
- 102000011753 Transient Receptor Potential Channels Human genes 0.000 description 2
- 244000273928 Zingiber officinale Species 0.000 description 2
- 235000006886 Zingiber officinale Nutrition 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 2
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 description 2
- 235000013614 black pepper Nutrition 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 235000019577 caloric intake Nutrition 0.000 description 2
- 150000003943 catecholamines Chemical class 0.000 description 2
- 210000004978 chinese hamster ovary cell Anatomy 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 230000005750 disease progression Effects 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 235000013373 food additive Nutrition 0.000 description 2
- 239000002778 food additive Substances 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 235000008397 ginger Nutrition 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 235000010460 mustard Nutrition 0.000 description 2
- 235000006180 nutrition needs Nutrition 0.000 description 2
- 230000003449 preventive effect Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 230000002889 sympathetic effect Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 230000001331 thermoregulatory effect Effects 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 240000004160 Capsicum annuum Species 0.000 description 1
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 1
- 235000007862 Capsicum baccatum Nutrition 0.000 description 1
- 108091005462 Cation channels Proteins 0.000 description 1
- 108091006146 Channels Proteins 0.000 description 1
- 235000016936 Dendrocalamus strictus Nutrition 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229920001732 Lignosulfonate Polymers 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 239000004368 Modified starch Substances 0.000 description 1
- 206010028817 Nausea and vomiting symptoms Diseases 0.000 description 1
- 239000006057 Non-nutritive feed additive Substances 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 206010048636 Self-induced vomiting Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 229940123223 TRPA1 agonist Drugs 0.000 description 1
- 102000003610 TRPM8 Human genes 0.000 description 1
- 101150111302 Trpm8 gene Proteins 0.000 description 1
- 229920001938 Vegetable gum Polymers 0.000 description 1
- CANRESZKMUPMAE-UHFFFAOYSA-L Zinc lactate Chemical compound [Zn+2].CC(O)C([O-])=O.CC(O)C([O-])=O CANRESZKMUPMAE-UHFFFAOYSA-L 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 239000000556 agonist Substances 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 238000005882 aldol condensation reaction Methods 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 235000015895 biscuits Nutrition 0.000 description 1
- 235000015496 breakfast cereal Nutrition 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- CNYFJCCVJNARLE-UHFFFAOYSA-L calcium;2-sulfanylacetic acid;2-sulfidoacetate Chemical compound [Ca+2].[O-]C(=O)CS.[O-]C(=O)CS CNYFJCCVJNARLE-UHFFFAOYSA-L 0.000 description 1
- 238000007707 calorimetry Methods 0.000 description 1
- 239000001728 capsicum frutescens Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 235000012182 cereal bars Nutrition 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000010630 cinnamon oil Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000007859 condensation product Substances 0.000 description 1
- 235000014510 cooky Nutrition 0.000 description 1
- 235000012495 crackers Nutrition 0.000 description 1
- 235000015140 cultured milk Nutrition 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000009982 effect on human Effects 0.000 description 1
- 239000008393 encapsulating agent Substances 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 238000010304 firing Methods 0.000 description 1
- 238000012757 fluorescence staining Methods 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 235000013350 formula milk Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 235000013882 gravy Nutrition 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 239000000416 hydrocolloid Substances 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 230000000622 irritating effect Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 235000013622 meat product Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 235000020166 milkshake Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 230000009456 molecular mechanism Effects 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 235000019520 non-alcoholic beverage Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 1
- 208000035824 paresthesia Diseases 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 229920001515 polyalkylene glycol Polymers 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 235000011962 puddings Nutrition 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 235000019685 rice crackers Nutrition 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 239000011257 shell material Substances 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 235000013570 smoothie Nutrition 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 235000014214 soft drink Nutrition 0.000 description 1
- 230000000392 somatic effect Effects 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 230000035924 thermogenesis Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- WGIWBXUNRXCYRA-UHFFFAOYSA-H trizinc;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O WGIWBXUNRXCYRA-UHFFFAOYSA-H 0.000 description 1
- 230000000304 vasodilatating effect Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000020852 very low calorie diet Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- 235000008924 yoghurt drink Nutrition 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
- 229960001939 zinc chloride Drugs 0.000 description 1
- 239000011746 zinc citrate Substances 0.000 description 1
- 235000006076 zinc citrate Nutrition 0.000 description 1
- 229940068475 zinc citrate Drugs 0.000 description 1
- 239000011576 zinc lactate Substances 0.000 description 1
- 229940050168 zinc lactate Drugs 0.000 description 1
- 235000000193 zinc lactate Nutrition 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/11—Aldehydes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Inorganic Chemistry (AREA)
- Botany (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Child & Adolescent Psychology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
アルコール飲料:498.8ppmまで、例えば、約435.6ppmなど。
焼成製品:367.4ppmまで、例えば、約273.8ppmなど。
チューインガム:6191.0ppmまで、例えば、約1533.0ppmなど。
調味料又は薬味:31.87ppmまで、例えば、約17.48ppmなど。
冷凍乳製品:77.96ppmまで、例えば、約72.98ppmなど。
フルーツアイス:900.0ppmまで、例えば、約900.0ppmなど。
ゼラチン又はプディング:109.4ppmまで、例えば、約100.3ppmなど。
グレービーソース:800.0ppmまで、例えば、約640.0ppmなど。
ハードキャンディ:1003.0ppmまで、例えば、約792.2ppmなど。
肉製品:39.09ppmまで、例えば、約6.97ppmなど。
非アルコール飲料:67.82ppmまで、例えば、約52.71ppmなど。
ソフトキャンディ:370.0ppmまで、例えば、約370.0ppmなど。
[0061]以下の非限定的な実施例は、許容できない味覚又は胃腸への影響を与えることなく、エネルギー消費、交感神経系の活性、又は脂肪の酸化のうち少なくとも1つを増大するために、シンナムアルデヒド及び亜鉛の組み合わせをTRPA1の相乗的な活性化を目的として投与するという概念を発展及び支持する科学的データを示す。
[0063]ヒト被験者に、プラシーボ、清涼香味剤、カプサイシン、又はシンナムアルデヒドが投与された。エネルギー消費が、摂取後80分間にわたり測定された。図3は、種々の化合物摂取後の、経過時間の関数として表されるエネルギー消費のグラフである。図4は、種々の化合物摂取後の、AUCに基づくエネルギー消費のグラフである。図3及び4は、シンナムアルデヒド摂取後に、プラシーボに比べエネルギー消費が増大することを示している。
[0069]ヒト被験者に、4.8ppmのカプサイシン又は350ppmのシンナムアルデヒドを含む組成物を投与した。図9は、比較味覚試験結果のグラフを示す。参加者の87.9%が、カプサイシン強度を非常に強いと判定したのに対し、シンナムアルデヒドに関しては、わずか20.5%であった。カプサイシン及びシンナムアルデヒドによって脂肪の酸化に対し同様の効果を達成するためには、カプサイシンの用量は香味剤として使用できる最大量(Fenaroli’s Handbook:Burdock,2010によると7ppm)の約1.5分の1であり、シンナムアルデヒドの用量は香味剤として使用できる最大量(Fenaroli’s Handbook:Burdock,2010によると6191.0ppm)の約17.5分の1である。
[0071]試験管内で、10μMシンナムアルデヒド及び0.3μM亜鉛、並びにこれらの組み合わせのそれぞれについて、CHO細胞のhTRPA1発現活性を測定した。結果は図10に表されており、シンナムアルデヒド及び亜鉛を組み合わせた場合(Cin+Zinc)の相乗効果が示されている。C+はこの試験における実験上の陽性対照を表しており、用量反応曲線により最大効果を与える50mMのシンナムアルデヒドである。
Claims (15)
- 体重維持を必要とする個体にシンナムアルデヒド及び亜鉛を含む組成物を投与することを含む、体重維持のための方法。
- 前記シンナムアルデヒドが、安全で摂取に耐えられる量であり、かつ前記亜鉛との組み合わせにより、エネルギー消費、交感神経系の活性、及び脂肪の酸化からなる群から選択される少なくとも1つの特性を増大するのに有効な量で、前記組成物中に存在する、請求項1に記載の方法。
- 前記組成物が、前記シンナムアルデヒドの少なくとも一部を供給する桂皮精油抽出物を含む、請求項1に記載の方法。
- 前記シンナムアルデヒドの少なくとも一部が、単離シンナムアルデヒド及び合成シンナムアルデヒドからなる群から選択される、請求項1に記載の方法。
- 減量を必要とする個体にシンナムアルデヒド及び亜鉛を含む組成物を投与することを含む、減量を促進するための方法。
- 肥満又は体重過多の危険を有する個体にシンナムアルデヒド及び亜鉛を含む組成物を投与することを含む、肥満又は体重過多を予防するための方法。
- 治療上有効な量のシンナムアルデヒド及び亜鉛を含む組成物を肥満個体に投与することを含む、肥満を治療するための方法。
- シンナムアルデヒド及び亜鉛を含む、減量用組成物。
- 前記シンナムアルデヒドが、安全で摂取に耐えられる量であり、かつ前記亜鉛との組み合わせにより、エネルギー消費、交感神経系の活性、及び脂肪の酸化からなる群から選択される少なくとも1つの特性を増大するのに有効な量で、前記組成物中に存在する、請求項8に記載の組成物。
- 前記組成物が、前記シンナムアルデヒドが31.87ppm〜6191ppmの香味付け濃度で存在する食品製品である、請求項8に記載の組成物。
- 前記組成物が、シンナムアルデヒド:亜鉛の比が1:0.5〜1:0.005の食品製品である、請求項8に記載の組成物。
- 前記組成物が、体重維持又は減量を促進するために治療上有効な量の追加の成分を更に含む、請求項8に記載の組成物。
- シンナムアルデヒド及び亜鉛を含む組成物を、減量プログラムを実施中の個体に投与することを含む、減量を促進するための方法。
- 前記減量プログラムが、低脂肪食、低炭水化物食、低カロリー食、超低カロリー食、持久力トレーニング、筋力トレーニング、及びこれらの組み合わせからなる群から選択される、請求項13に記載の方法。
- タンパク質、炭水化物、脂肪、及びこれらの組み合わせからなる群から選択される構成成分に、シンナムアルデヒド及び亜鉛を添加することを含む、減量用食品製品を製造する方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201461968096P | 2014-03-20 | 2014-03-20 | |
US61/968,096 | 2014-03-20 | ||
PCT/EP2015/054916 WO2015140002A1 (en) | 2014-03-20 | 2015-03-10 | Methods and compositions for using cinnamaldehyde and zinc for weight management |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2017509639A true JP2017509639A (ja) | 2017-04-06 |
JP6669665B2 JP6669665B2 (ja) | 2020-03-18 |
Family
ID=52706142
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2016557635A Active JP6669665B2 (ja) | 2014-03-20 | 2015-03-10 | 体重管理にシンナムアルデヒド及び亜鉛を用いるための方法及び組成物 |
Country Status (9)
Country | Link |
---|---|
US (2) | US20160339058A1 (ja) |
EP (1) | EP3133941B1 (ja) |
JP (1) | JP6669665B2 (ja) |
CN (1) | CN106028837B (ja) |
AU (1) | AU2015230895B2 (ja) |
BR (1) | BR112016017765B1 (ja) |
CA (1) | CA2939843C (ja) |
ES (1) | ES2808626T3 (ja) |
WO (1) | WO2015140002A1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2017526643A (ja) * | 2014-07-18 | 2017-09-14 | ネステク ソシエテ アノニム | 桂皮アルデヒド及び亜鉛を含む組成物並びにかかる組成物の使用方法 |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2016269605B2 (en) * | 2015-06-05 | 2021-03-04 | Société des Produits Nestlé S.A. | Compositions comprising cinnamaldehyde and zinc and methods of using such compositions |
US10548936B2 (en) * | 2017-04-27 | 2020-02-04 | Nanzheng Cheng | Method for reducing weight |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS52116421A (en) * | 1976-03-10 | 1977-09-29 | Procida | Stabilized ethylene bisdithiocarbamic acid metal salts* compositions containing said salts* stabilized compositions and process for stabilization thereof |
JP2002531513A (ja) * | 1998-12-07 | 2002-09-24 | エコスマート テクノロジーズ,インコーポレーテッド | 天然植物精油をシグナル伝達調節物質とともに用いた癌治療薬配合物および方法 |
EP1654937A1 (de) * | 2004-11-05 | 2006-05-10 | Salus-Haus GmbH & Co. KG | Momordica charantia-Zimt-Zubereitung |
US20130172387A1 (en) * | 2011-12-29 | 2013-07-04 | Yu-Chun Hung | Method and composition for prolonging analgesic effect of local anesthetic |
JP2014505101A (ja) * | 2011-02-15 | 2014-02-27 | コルゲート・パーモリブ・カンパニー | 矯味されたオーラルケア組成物 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2771632B1 (fr) * | 1997-12-01 | 2000-03-17 | Seppic Sa | Composition synergique comprenant au moins un lipoaminoacide et au moins un glycol; application en cosmetique |
US20020136782A1 (en) * | 2001-01-18 | 2002-09-26 | Fleischner Albert M. | Composition patent for solid-dosage form of weight loss product |
US20040071681A1 (en) * | 2002-10-10 | 2004-04-15 | Lydia Muller | Method and composition for reducing cravings for a craved substance |
CN101143010B (zh) * | 2006-09-15 | 2012-07-11 | 上海瑞品实业有限公司 | 糖尿病患者专用营养食品制备方法 |
JP2010083787A (ja) * | 2008-09-30 | 2010-04-15 | Kirin Holdings Co Ltd | Cb1受容体アンタゴニストとしての桂皮アルデヒドおよび桂皮抽出物 |
GB2477534A (en) * | 2010-02-05 | 2011-08-10 | Ajit Lalvani | Composition for the stimulation and regulation of the hair follicle |
KR20110123002A (ko) * | 2010-05-06 | 2011-11-14 | 경희대학교 산학협력단 | Ampk 활성화제 |
US20130344180A1 (en) * | 2012-06-26 | 2013-12-26 | Yl Holdings, Inc. | Weight loss and satiation composition |
-
2015
- 2015-03-10 US US15/116,895 patent/US20160339058A1/en not_active Abandoned
- 2015-03-10 CA CA2939843A patent/CA2939843C/en active Active
- 2015-03-10 BR BR112016017765-7A patent/BR112016017765B1/pt active IP Right Grant
- 2015-03-10 JP JP2016557635A patent/JP6669665B2/ja active Active
- 2015-03-10 CN CN201580007648.4A patent/CN106028837B/zh active Active
- 2015-03-10 AU AU2015230895A patent/AU2015230895B2/en active Active
- 2015-03-10 WO PCT/EP2015/054916 patent/WO2015140002A1/en active Application Filing
- 2015-03-10 EP EP15711442.2A patent/EP3133941B1/en active Active
- 2015-03-10 ES ES15711442T patent/ES2808626T3/es active Active
-
2022
- 2022-01-19 US US17/578,844 patent/US20220133782A1/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS52116421A (en) * | 1976-03-10 | 1977-09-29 | Procida | Stabilized ethylene bisdithiocarbamic acid metal salts* compositions containing said salts* stabilized compositions and process for stabilization thereof |
JP2002531513A (ja) * | 1998-12-07 | 2002-09-24 | エコスマート テクノロジーズ,インコーポレーテッド | 天然植物精油をシグナル伝達調節物質とともに用いた癌治療薬配合物および方法 |
EP1654937A1 (de) * | 2004-11-05 | 2006-05-10 | Salus-Haus GmbH & Co. KG | Momordica charantia-Zimt-Zubereitung |
JP2014505101A (ja) * | 2011-02-15 | 2014-02-27 | コルゲート・パーモリブ・カンパニー | 矯味されたオーラルケア組成物 |
US20130172387A1 (en) * | 2011-12-29 | 2013-07-04 | Yu-Chun Hung | Method and composition for prolonging analgesic effect of local anesthetic |
Non-Patent Citations (6)
Title |
---|
"Mineral Mix S10001", OPENSOURCE DIETS(R), JPN6019025291, 1977, ISSN: 0004085336 * |
"Mineral Mix S10026", OPENSOURCE DIETS(R), JPN6019025287, 18 January 1996 (1996-01-18), ISSN: 0004085337 * |
"Muesli Appel-Kaneel Smaak", MINTEL GNPD, vol. ID#:288984, JPN6019025289, August 2004 (2004-08-01), ISSN: 0004085338 * |
ASIAN-AUST. J. ANIM. SCI., vol. 25, no. 8, JPN6018044705, August 2012 (2012-08-01), pages 1178 - 1183, ISSN: 0003920059 * |
INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND BIO-SCIENCE, vol. 2, no. 5, JPN6018044706, 27 October 2013 (2013-10-27), pages 131 - 145, ISSN: 0004085340 * |
J NUTR SCI VITAMINOL, vol. 58, JPN6018033655, 2012, pages 9 - 13, ISSN: 0004085335 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2017526643A (ja) * | 2014-07-18 | 2017-09-14 | ネステク ソシエテ アノニム | 桂皮アルデヒド及び亜鉛を含む組成物並びにかかる組成物の使用方法 |
Also Published As
Publication number | Publication date |
---|---|
WO2015140002A1 (en) | 2015-09-24 |
BR112016017765B1 (pt) | 2021-09-14 |
EP3133941B1 (en) | 2020-07-01 |
CN106028837B (zh) | 2019-12-27 |
CA2939843C (en) | 2023-08-29 |
US20160339058A1 (en) | 2016-11-24 |
AU2015230895A1 (en) | 2016-08-11 |
AU2015230895B2 (en) | 2018-12-13 |
BR112016017765A8 (pt) | 2021-03-23 |
US20220133782A1 (en) | 2022-05-05 |
CA2939843A1 (en) | 2015-09-24 |
ES2808626T3 (es) | 2021-03-01 |
EP3133941A1 (en) | 2017-03-01 |
CN106028837A (zh) | 2016-10-12 |
JP6669665B2 (ja) | 2020-03-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20220133782A1 (en) | Methods and compositions for using cinnamaldehyde and zinc for weight management | |
JP7163460B2 (ja) | 桂皮アルデヒド及び亜鉛を含む組成物並びにかかる組成物の使用方法 | |
AU2024200698A1 (en) | Methods and compositions for increasing energy expenditure using cinnamaldehyde | |
JP6869286B2 (ja) | 桂皮アルデヒド及び亜鉛を含む組成物並びにかかる組成物の使用方法 | |
JP6513103B2 (ja) | 嚥下を改善するためシンナムアルデヒド及び亜鉛を含む組成物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20180202 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20181120 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20190206 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20190520 |
|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A712 Effective date: 20190614 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20190730 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20191025 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20200130 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20200225 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20200227 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6669665 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |